Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 20,116 | 23,526 | 23,167 | 20,206 | 24,552 |
| Operating Income | -20,116 | -23,526 | -23,167 | -20,206 | -24,552 |
| Other Income | 761 | 880 | 701 | 416 | -61 |
| Pre-tax Income | -19,355 | -22,646 | -22,466 | -19,790 | -24,613 |
| Net Income Continuous | -19,355 | -22,646 | -22,466 | -19,790 | -24,613 |
| Net Income | $-19,355 | $-22,646 | $-22,466 | $-19,790 | $-24,613 |
| EPS Basic Total Ops | -9.80 | -11.62 | -11.48 | -10.08 | -12.61 |
| EPS Basic Continuous Ops | -9.87 | -11.56 | -11.48 | -10.12 | -12.59 |
| EPS Diluted Total Ops | -9.80 | -11.62 | -11.48 | -10.08 | -12.61 |
| EPS Diluted Continuous Ops | -9.87 | -11.56 | -11.48 | -10.12 | -12.59 |
| EBITDA(a) | $-19,624 | $-23,027 | $-22,678 | $-19,733 | $-24,107 |